Evidence for an association between brain-derived neurotrophic factor Val66Met gene polymorphism and general intellectual ability in early-onset schizophrenia

Israel Journal of Psychiatry and Related Sciences

Volumn 49, Issue 2, 2012, Pages 137-144

  Vyas, Nora S ^a,b   Basant, K ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADOLESCENT; ADULT; FAMILY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INTELLIGENCE; MAJOR DEPRESSION; MALE; MIDDLE AGED; ONSET AGE; SCHIZOPHRENIA; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FAMILY; FEMALE; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; WECHSLER SCALES;

EID: 84857850384     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Gosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity dependent survival of cortical neurons. Science 1994; 263:1618-1622.
2. Segal RA, Pomeroy SL, Stiles CD. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J Neurosci 1995;15:4970-4981.
3. Lewin GR, Barde, YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19: 289-317.
4. Kang H, Shuman EM. Long lasting neurotrophin induced enhancement of synaptic transmission in the adult hippocampus. Science 1995;267:1658-1662.
5. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD. Human and rat brain derived neurotrophic factor and neurotrophin 3: gene structures, distributions, and chromosomal localizations. Genomics 1991;10:558-568.
6. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995;18:223-253.
7. Lu B. BDNF and activity dependent synaptic modulation. Learn Mem 2003;10:86-98.
8. Romanczyk TB, Weickert CS, Webster MJ, Herman MM, Akil M, Kleinman JE. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci 2002;15:269-280.
9. Neves Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family based association study. Am J Hum Genet 2002;71:651-655.
10. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES. Family based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain derived neutrophic factor. Mol Psychiatry 2002;7:579-593.
11. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura but in manoeiyot T, Katsu T, Tanaka Y, Hamamura T, Kuroda S. Association study of the brain derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003;337:17-20.
12. Muglia P, Vicente AM, Verga M, King N, Macciardi F, Kennedy JL. Association between the BDNF gene and schizophrenia. Mol Psychiatry 2003;8:146-147.
13. Rosa A, Cuesta MJ, Fatjó Vilas M, Peralta V, Zarzuela A, Fañanás L. The Val66Met polymorphism of the brain derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family based association study. Am J Med Genet B Neuropsychiatr Genet 2006;141B:135-138.
14. Garzon D, Yu G, Fahnestock M. A new brain derived neurotrophic factor transripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 2002;82:1058-1064.
15. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Müller U, Förstl H, Kurz A. A polymorphism of the brain derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 2002;7:782-785.
16. Ribasés M, Gratacòs M, Armengol L, de Cid R, Badía A, Jiménez L, Solano R, Vallejo J, Fernández F, Estivill X. Met66 in the brain derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 2003;8:745-751.
17. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A, Weder AB, Burmeister M. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003; 28:397-401.
18. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain derived neurotrophic factor (BDNF) gene are strongly associated with obsessive compulsive disorder. Am J Hum Genet 2003;73:370-376.
19. Angelucci F, Brene S, Mathe AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005;10:345-352.
20. Shoval G, Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol 2005;15:319-329.
21. Eaton MJ, Staley JK, Globus MY, Whittemore SR. Developmental regulation of early serotonergic neuronal differentiation: the role of brain derived neurotrophic factor and membrane depolarization. Dev Biol 1995;170:169-182.
22. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, et al. Abnormal expression of brain derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 2000;5:293-300.
23. Durany N, Michel T, Zöchling R, Boissl KW, Cruz Sánchez FF, Riederer P, et al. Brain derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001;52:79-86.
24. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, et al. Decreased levels of brain derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002;110:249-257.
25. Pirildar S, Gonul AS, Taneli F, Akdeniz F. Low serum levels of brain derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:709-713.
26. Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, Shinoda N, Nakazato M, Kumakiri C, Okada S, Iyo M. Serum brain derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 2003;351:111-114.
27. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
28. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. Brain derived neurotrophic factor val66met polymorphism affects human memory related hippocampal activity and predicts memory performance. J Neurosci 2003;23:6690-6694.
29. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer Lindenberg A, Weinberger DR.The brain derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004;24:10099-10102.
30. Neves Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005;10:208-212.
31. Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK. Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 2009;194:313-318.
32. Tsai SJ, Hong CJ, Yu YW, Chen TJ. Association study of a brain derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 2004,49:13-16.
33. Whalley HC, Baig BJ, Hall J, Job DE, McIntosh AM, Cunningham Owens DG, Johnstone EC, Lawrie SM. Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1474-1482.
34. Payne RW. Cognitive abnormalities. In: Eysenck HJ, editor. Handbook of abnormal psychology. London: Pitman Medical Publishing, 1960.
35. Aylward E, Walker E, Bettes B. Intelligence in schizophrenia: Meta analysis of the research. Schizophr Bull 1984;10:430-459.
36. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L. A meta analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev 2005; 15:73-95.
37. Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: An update. Schizophr Res 2005;74:15-26.
38. Fagerlund B, Pagsberg AK, Hemmingsen, RP. Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders. Schizophr Res 2006;8:30-39.
39. Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S. The Maudsley Early Onset Schizophrenia Study. Predictors of psychosocial outcome at 4 year follow up. Eur Child Adolesc Psychiatry 2007;16:465-470.
40. Vyas NS, Kumra S, Puri BK. What insights can we gain from studying early onset schizophrenia? The neurodevelopmental pathway and beyond. Exp Rev Neurotherapeutics 2010;10:1243-1247.
41. Asarnow RF, Asamen J, Granholm E, Sherman T, Watkins JM, Williams ME. Cognitive/neuropsychological studies of children with a schizophrenic disorder. Schizophr Bull 1994;20:647-669.
42. Banaschewski T, Schulz E, Martin M, Remschmidt H. Cognitive functions and psychopathological symptoms in early onset schizophrenia. Eur Child Adolesc Psychiatry 2000;9:11-20.
43. Hollis C. Developmental precursors of child and adolescent onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry 2003;182:37-44.
44. Mesholam Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first episode schizophrenia: A meta analytic review. Neuropsychology 2009;23:315-336.
45. Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Abukmeil SS, et al. Neuropsychological change in young people at high risk for schizophrenia: Results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med 2000;30:1111-1121.
46. Goldstein JM, Seidman LJ, Buka SL, Horton NJ, Donatelli JL, Rieder RO, Tsuang MT. Impact of genetic vulnerability and hypoxia on overall intelligence by age 7 in offspring at high risk for schizophrenia compared with affective psychoses. Schizophr Bull 2000; 26:323-334.
47. Byrne M, Clafferty BA, Cosway R, Grant E, Hodges A, Whalley HC, Lawrie SM, Owens DG, Johnstone EC. Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol 2003;112:38-48.
48. Seidman LJ, Giuliano AJ, Smith CW, Stone WS, Glatt SJ, Meyer E, Faraone SV, Tsuang MT, Cornblatt B. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: Results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr Bull 2006;32:507-524.
49. Snitz BE, Macdonald AW 3rd, Carter CS. Cognitive deficits in unaffected first degree relatives of schizophrenia patients: A meta analytic review of putative endophenotypes. Schizophr Bull 2006;32:179-194.
50. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: A meta analytic review. Am J Psychiatry 2008;165:579-587.
51. Dickinson D, Harvey PD. Systemic hypotheses for generalized cognitive deficits in schizophrenia: A new take on an old problem. Schizophr Bull 2009;35:403-414.
52. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC, 1994.
53. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM IV TR Axis 1 DisordersResearch Version, Patient Edition (SCID I/P). Biometrics Research. New York, N.Y.: New York State Psychiatric Institute, 2001.
54. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM IV TR Axis 1 Disorders Research Version, Non patient Edition (SCID I/NP). New York, N.Y.: Biometrics Research, New York State Psychiatric Institute, 2002.
55. Wechsler D. Wechsler Adult Intelligence Scale Revised. Cleveland, Ohio: The Psychological Corporation, 1981.
56. Wechsler D. Manual for the Wechsler Intelligence Scale for Children (Third Edition). London, U.K.: The Psychological Corporation, 1992.
57. Nelder J, Wedderburn R. Generalized linear models. J R Stat Soc Ser A 1972;135:370-384.
58. Hardin J, Hilbe J. Generalized estimating equations. London: Chapman and Hall, 2003.
59. Tan YL, Zhou DF, Cao LY, Zou YZ, Wu GY, Zhang XY. Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr Res 2005;77:355-356.
60. Harris SE, Fox H, Wright AF, Hayward C, Starr JM, Whalley LJ, Deary IJ. The brain derived neurotrophic factor Val66Met polymorphism is associated with age related change in reasoning skills. Mol Psychiatry 2006;11:505-513.
61. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006;63:731-740.
62. Chung S, Chung HY, Jung J, Chang JK, Hong JP. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain derived neurotrophic factor gene in male schizophrenic patients. Compr Psychiatry 2010;51:367-372.
63. Manns JR, Hopkins RO, Squire LR. Semantic memory and the human hippocampus. Neuron 2003;38:127-133.
64. Vargha Khadem F, Gadian DG, Watkins KE, Connelly A, Van Paesschen W, Mishkin M. Differential Effects of early hippocampal pathology on episodic and semantic memory. Science 1997;277:376-380.
65. Moscovitch M, Nadel L, Winocur G, Gilboa A, Rosenbaum RS. The cognitive neuroscience of remote episodic, semantic and spatial memory. Curr Opin Neurobiol 2006;16:179-190.
66. Kazui H, Hashimoto M, Hirono N, Mori E. Nature of personal semantic memory: Evidence from Alzheimer's disease. Neuropsychologia 2003;41:981-988.
67. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Ed., Text Revision. Washington, DC, 2000.
68. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007;33:905-911.
69. Vyas NS, Patel NH, Puri BK. Neurobiological and phenotypic expression in early onset schizophrenia. Early Interv Psychiatry 2011;5:3-14.
70. Gogtay N, Vyas NS, Testa R, Wood SJ, Pantelis C. Age of onset of schizophrenia: Perspectives from structural neuroimaging studies. Schizophr Bull 2011;37:504-513.